Utah Medical Products (UTMD) EPS (Weighted Average and Diluted) (2010 - 2026)

Utah Medical Products' EPS (Weighted Average and Diluted) history runs 17 years deep, the most recent figure standing at $0.82 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) fell 10.87% year-over-year to $0.82; the TTM figure through Mar 2026 stood at $3.38 (down 10.82% YoY), while the FY2025 annual figure was $3.48, down 12.12% from the prior year.
• EPS (Weighted Average and Diluted) was $0.82 for Q1 2026 at Utah Medical Products, up from $0.8 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.25 in Q4 2022 to a low of $0.8 in Q4 2025.
• Historically, EPS (Weighted Average and Diluted) has averaged $1.02 across 5 years, with a median of $1.03 in 2024.
• The sharpest annual moves came in 2023 and 2024: EPS (Weighted Average and Diluted) advanced 20.83% in 2023, then dropped 27.12% in 2024.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $1.25 in 2022, then declined by 5.6% to $1.18 in 2023, then fell by 27.12% to $0.86 in 2024, then decreased by 6.98% to $0.8 in 2025, then increased by 2.5% to $0.82 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.82 (Q1 2026), $0.8 (Q4 2025), and $0.82 (Q3 2025), per Business Quant data.